A physician-guided plan may help reduce side effects through slower dose escalation, hydration guidance, meal-size changes, constipation prevention, protein planning, and medication review
Availability of Data and Material Not applicable Ethics Approval Not applicable Consent to Participate Not applicable Consent for Publication Not applicable Author Contributions All authors (F.P, S.M.O, J.M, F.C.S) meet ICMJE authorship criteria, made substantial contributions to the conception and design of the work and to drafting or critically revising the manuscript, approved the final version, and agree to be accountable for all aspects of the work
They differ only in available doses and packaging
Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment
By Application - Type 2 diabetes mellitus segment was valued at USD 23.54 billion in 2023 By Route of Administration - Subcutaneous injection segment accounted for the largest market revenue share in 2023 Market Size & Forecast Market Opportunities: USD 123.03 billion Market Future Opportunities: USD 100.08 billion CAGR from 2024 to 2029 : 25.3% Market Summary The GLP 1 analogues market is undergoing a significant transformation, driven by its expanding role in addressing interconnected metabolic diseases
For GLP-1 drugs for diabetes, Blue Cross utilization management procedures ensure that members who have type 2 diabetes are the only members who use these products